K. Manjunatha Prasad

This study shows that truncating guide RNAs can modulate base editing outcomes by reducing bystander editing while preserving on-target conversion in multiple contexts.

This study demonstrates the use of base editors to precisely correct various β-thalassemic mutations in human erythroid cells, showing efficient and scarless mutation correction with normal hemoglobin variants.

This study uses CRISPR base editing to identify novel mutations in the HBG promoter that increase fetal hemoglobin expression without harmful effects.